Volume : 11, Issue : 09, September – 2024
Title:
COMPARATIVE ANALYSIS OF ANTIHYPERTENSIVE THERAPIES DURING PREGNANCY: LONG-TERM MATERNAL AND NEONATAL HEALTH OUTCOME
Authors :
Dr Naila Sarfraz, Dr Tehmina Aziz, Dr Iqra Javed
Abstract :
Objective: The primary objective of this study is to evaluate and compare the long-term maternal and neonatal health outcomes associated with different antihypertensive therapies used during pregnancy. Specifically, the study aims to determine the effectiveness of these therapies in controlling maternal blood pressure, preventing maternal cardiovascular complications post-pregnancy, and their influence on neonatal health parameters such as birth weight and APGAR scores.
Methods: This is a comparative, observational study involving 225 pregnant women diagnosed with hypertension. The patients were randomized to receive one of three antihypertensive therapies: Therapy A, Therapy B, or Therapy C. The study tracked the maternal and neonatal outcomes over an 18-month period following delivery. Inclusion criteria for the study included pregnant women diagnosed with hypertension between 12–20 weeks of gestation. Women with pre-existing chronic kidney disease or other severe medical conditions were excluded from the study. Data collected included maternal blood pressure control, development of preeclampsia, neonatal birth weight, APGAR scores, and long-term maternal cardiovascular health. Statistical analysis was performed using Kaplan-Meier curves, logistic regression, and Cox proportional hazards models.
Results: A total of 225 patients participated in the study, with 75 patients in each treatment group. For maternal outcomes, 85% of patients in the Therapy A group achieved adequate blood pressure control by 30 weeks of gestation, while 12% developed preeclampsia post-delivery and 8% experienced long-term cardiovascular complications. In the Therapy B group, 70% of patients achieved blood pressure control by 32 weeks, but 18% developed preeclampsia and 10% experienced cardiovascular issues in the long term. In the Therapy C group, 75% achieved blood pressure control by 30 weeks, with 15% developing preeclampsia and 7% encountering cardiovascular complications post-pregnancy.
Regarding neonatal outcomes, the average birth weight in the Therapy A group was 3.2 kg, with 92% of neonates scoring normal APGAR results at 5 minutes. Therapy B saw an average birth weight of 2.9 kg, with 87% of neonates having normal APGAR scores. Therapy C’s neonatal outcomes included an average birth weight of 3.1 kg, with 90% of newborns scoring normally on APGAR tests. Neonatal intensive care unit (NICU) admissions were more frequent in the Therapy B group (15%) compared to Therapy A (10%) and Therapy C (8%).
Conclusions: The study concludes that Therapy A provided the most effective blood pressure control during pregnancy, resulting in the lowest incidence of long-term maternal cardiovascular complications. Neonatal outcomes were also more favorable with Therapy A and Therapy C, with better birth weight and APGAR scores compared to Therapy B. However, Therapy B was associated with higher rates of neonatal complications, including a higher rate of NICU admissions and a greater likelihood of preeclampsia post-delivery. These results highlight the need for further research to confirm the long-term safety and efficacy of antihypertensive therapies during pregnancy, as they play a crucial role in both maternal and neonatal health.
Cite This Article:
Please cite this article in press Naila Sarfraz et al., Comparative Analysis Of Antihypertensive Therapies During Pregnancy: Long-Term Maternal And Neonatal Health Outcome., Indo Am. J. P. Sci, 2024; 11 (09).
Number of Downloads : 10
References:
1- Dublin S, Idu A, Avalos LA, Cheetham TC, Easterling TR, Chen L, Holt VL, Nance N, Bider-Canfield Z, Neugebauer RS, Reynolds K. Maternal and neonatal outcomes of antihypertensive treatment in pregnancy: A retrospective cohort study. PloS one. 2022 May 16;17(5):e0268284.
2- Bellos I, Pergialiotis V, Papapanagiotou A, Loutradis D, Daskalakis G. Comparative efficacy and safety of oral antihypertensive agents in pregnant women with chronic hypertension: a network metaanalysis. American journal of obstetrics and gynecology. 2020 Oct 1;223(4):525-37.
3- Garovic VD, White WM, Vaughan L, Saiki M, Parashuram S, Garcia-Valencia O, Weissgerber TL, Milic N, Weaver A, Mielke MM. Incidence and long-term outcomes of hypertensive disorders of pregnancy. Journal of the American College of Cardiology. 2020 May 12;75(18):2323-34.
4- Palatnik A, Mele L, Casey BM, Varner MW, Sorokin Y, Reddy UM, Wapner RJ, Thorp Jr JM, Saade GR, Tita AT, Rouse DJ. Association between hypertensive disorders of pregnancy and long-term neurodevelopmental outcomes in the offspring. American journal of perinatology. 2022 Jul;39(09):0921-9.
5- Bone JN, Sandhu A, Abalos ED, Khalil A, Singer J, Prasad S, Omar S, Vidler M, von Dadelszen P, Magee LA. Oral antihypertensives for nonsevere pregnancy hypertension: systematic review, network meta-and trial sequential analyses. Hypertension. 2022 Mar;79(3):614-28.
6- Abu-Awwad SA, Craina M, Gluhovschi A, Boscu L, Bernad E, Iurciuc M, Abu-Awwad A, Iurciuc S, Tudoran C, Bernad R, Maghiari AL. Comparative Analysis of Neonatal Effects in Pregnant Women with Cardiovascular Risk versus Low-Risk Pregnant Women. Journal of Clinical Medicine. 2023 Jun 16;12(12):4082.
7- Ushida T, Kotani T, Hayakawa M, Hirakawa A, Sadachi R, Nakamura N, Moriyama Y, Imai K, Nakano-Kobayashi T, Kikkawa F. Antenatal corticosteroids and preterm offspring outcomes in hypertensive disorders of pregnancy: a Japanese cohort study. Scientific reports. 2020 Jun 9;10(1):9312.
8- Lyu X, Zhang W, Zhang J, Wei Y, Guo X, Cui S, Yan J, Zhang X, Qiao C, Zhou R, Gu W. Morbidity and maternal and infant outcomes of hypertensive disorder in pregnancy in China in 2018. The Journal of Clinical Hypertension. 2021 Jun;23(6):1194-204.
9- Sinkey RG, Battarbee AN, Bello NA, Ives CW, Oparil S, Tita AT. Prevention, diagnosis, and management of hypertensive disorders of pregnancy: a comparison of international guidelines. Current hypertension reports. 2020 Sep;22:1-0.
10- Tita AT, Szychowski JM, Boggess K, Dugoff L, Sibai B, Lawrence K, Hughes BL, Bell J, Aagaard K, Edwards RK, Gibson K. Treatment for mild chronic hypertension during pregnancy. New England Journal of Medicine. 2022 May 12;386(19):1781-92.
11- Kono Y, Yonemoto N, Nakanishi H, Hosono S, Hirano S, Kusuda S, Fujimura M. A retrospective cohort study on mortality and neurodevelopmental outcomes of preterm very low birth weight infants born to mothers with hypertensive disorders of pregnancy. American Journal of Perinatology. 2022 Oct;39(13):1465-77.
12- Wu P, Green M, Myers JE. Hypertensive disorders of pregnancy. bmj. 2023 Jun 30;381.
13- Al-Duqhaishi T, Al Rajaibi H, Al Waili K, Al Rasadi K, Nadar SK, Al Hashmi K. Antihypertensive drugs and perinatal outcomes in hypertensive women attending a specialized tertiary hospital. Oman Medical Journal. 2022 Mar;37(2):e354.
14- Chandrasekaran S, Badell ML, Jamieson DJ. Management of chronic hypertension during pregnancy. Jama. 2022 May 3;327(17):1700-1.
15- Tsakiridis I, Giouleka S, Arvanitaki A, Mamopoulos A, Giannakoulas G, Papazisis G, Athanasiadis A, Dagklis T. Chronic hypertension in pregnancy: synthesis of influential guidelines. Journal of Perinatal Medicine. 2021 Sep 27;49(7):859-72.
16- Society for Maternal-Fetal Medicine, Publications Committee. Society for Maternal-Fetal Medicine statement: antihypertensive therapy for mild chronic hypertension in pregnancy–the chronic hypertension and pregnancy trial. American Journal of Obstetrics and Gynecology. 2022 Aug 1;227(2):B24-7.
17- Wertaschnigg D, Selvaratnam RJ, Rolnik DL, Davey MA, Anil S, Mol BW, Reddy M, da Silva Costa F. Hypertensive disorders in pregnancy–Trends over eight years: A population-based cohort study. Pregnancy hypertension. 2022 Jun 1;28:60-5.
18- Poon LC, Nguyen‐Hoang L, Smith GN, Bergman L, O’Brien P, Hod M, Okong P, Kapur A, Maxwell CV, McIntyre HD, Jacobsson B. Hypertensive disorders of pregnancy and long‐term cardiovascular health: FIGO best practice advice. International Journal of Gynecology & Obstetrics. 2023 Jan;160:22-34.
19- Agrawal A, Wenger NK. Hypertension during pregnancy. Current hypertension reports. 2020 Sep;22(9):64.
20- Dumitrascu‐Biris D, Nzelu D, Dassios T, Nicolaides K, Kametas NA. Chronic hypertension in pregnancy stratified by first‐trimester blood pressure control and adverse perinatal outcomes: A prospective observational study. Acta Obstetricia et Gynecologica Scandinavica. 2021 Jul;100(7):1297-304.
21- Garovic VD, Dechend R, Easterling T, Karumanchi SA, McMurtry Baird S, Magee LA, Rana S, Vermunt JV, August P. Hypertension in pregnancy: diagnosis, blood pressure goals, and pharmacotherapy: a scientific statement from the American Heart Association. Hypertension. 2022 Feb;79(2):e21-41.
22- Wertaschnigg D, Wang R, Reddy M, Costa FD, Mol BW, Rolnik DL. Treatment of severe hypertension during pregnancy: we still do not know what the best option is. Hypertension in pregnancy. 2020 Jan 2;39(1):25-32.